Company intelligence / Profile preview

SurGenTec

Boca Raton, Florida, United Statessurgentec.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

SurGenTec has received multiple FDA 510(k) clearances for its innovative orthopedic and spine technologies. Its flagship products—such as the OsteoFlo HydroPutty synthetic bone graft and the 3D GraftRasp System—have demonstrated excellent preclinical results in terms of bone growth and integration. The company’s solutions are used both domestically in the US and internationally[3][5].

Therapeutic areas: OtherRheumatologyNeurology
Modalities: DeviceSynthetic biologicBone graft substituteBiologicCellular matrixAllograft material
Industry: Implantable Medical Devices

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on SurGenTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SurGenTec.

Explore the full profile